Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Stock Chart & Stats
$1.12
-$0.13(-1.86%)
At close: 4:00 PM EST
$1.12
-$0.13(-1.86%)
Day’s Range― - ―
52-Week Range$0.78 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)1.69M
Market Cap
$31.36M
Enterprise Value$37.36M
Total Cash (Recent Filing)$12.55M
Total Debt (Recent Filing)$12.30M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
Mar 16, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding38,435,524
10 Day Avg. Volume832,806
30 Day Avg. Volume1,692,804
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)9.84
Price to Sales (P/S)7.47
P/FCF Ratio-52.30
Enterprise Value/Market Cap1.19
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit1.35
Enterprise Value/Ebitda-3.70
Forecast
1Y Price Target
$6.50Price Target Upside480.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.38
Revenue Forecast (FY)$40.19M
Bulls Say, Bears Say
Bulls Say
Manufacturing CapabilitiesThe new manufacturing facility and ongoing improvements are expanding gross margin and increasing monthly unit manufacturing capabilities.
Market ExpansionMyoPro is well-positioned to address a market population that is largely untapped.
Revenue GrowthMYO's 3Q25 revenue was ahead of expectations primarily due to the international segment and US orthotics and prosthetics (O&P) revenues at record levels.
Bears Say
Cash Flow ManagementAn average cash burn of $3.0M per quarter through 2026 is expected, suggesting challenges in managing cash flow.
Lead Generation ChallengesLower revenue estimates and a reduced price target reflect ongoing challenges with lead generation and authorizations.
Revenue GuidanceLower-than-expected 3Q25 revenue guidance and reduced full-year 2025 guidance highlight challenges with lead quality and slower authorizations.
Myomo News
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $0.78 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $31.36M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is Mar 16, 2026 which is in 120 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Nov 10, 2025. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.108 by $0.018.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.08.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 38,435,524 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.108. Following the earnings report the stock price went down -7.609%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
Myomo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.50 (480.36% Upside)
$6.50 (480.36% Upside)
Blogger Sentiment
Neutral
MYO Sentiment 50%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $159.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.1%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.19%
12-Months-Change
Fundamentals
Return on Equity
-100.51%
Trailing 12-Months
Asset Growth
108.90%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc. is a medical technology company that specializes in developing wearable robotic devices designed to restore mobility for individuals with upper limb disabilities. The company primarily operates in the healthcare sector, focusing on rehabilitation and assistive technologies. Myomo's core products include myoelectric orthoses that enable users to control their arm and hand movements through muscle signals, enhancing their ability to perform daily activities and improving their quality of life.
MYO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable revenue growth and strategic expansions, particularly in international markets and the O&P channel. However, challenges such as decreased gross margin, increased operating loss, and high cash burn were significant concerns. The company's reaffirmation of financial guidance and steps to optimize costs and advertising were positive, but the issues with Medicare Advantage revenue and increased losses present challenges.View all MYO earnings summariesMYO Stock 12 Month Forecast
Average Price Target
$6.50
▲(480.36% Upside)
Technical Analysis
Electrocore
―
Modular Medical
―
Vicarious Surgical
―
Adagio Medical Holdings
―
Inspira Technologies Oxy BHN
―
Ownership Overview
17.05% Insiders
6.45% Mutual Funds
10.44% Other Institutional Investors
59.30% Public Companies and
Individual Investors